DERM
Journey Medical Corporation
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.86
−0.51%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+32.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 2, 2026 | Smith Justin Adam · director | A-Award | 50,000 | $0.00 |
| Jul 2, 2026 | Toledano Miranda Jayne · director | A-Award | 50,000 | $0.00 |
| Jul 2, 2026 | Herskowitz Neil · director | A-Award | 50,000 | $0.00 |
| Jun 29, 2026 | Toledano Miranda Jayne · director | A-Award | 10,000 | $0.00 |
| Jun 26, 2026 | Herskowitz Neil · director | A-Award | 10,000 | $0.00 |
| Jun 26, 2026 | Pearce Michael Cooper · director | A-Award | 10,000 | $0.00 |
| Jun 26, 2026 | Smith Justin Adam · director | A-Award | 10,000 | $0.00 |
| Jun 26, 2026 | ROSENWALD LINDSAY A MD · director | A-Award | 10,000 | $0.00 |
| Apr 24, 2026 | Maraoui Claude · director, officer: President & CEO | A-Award | 82,915 | $5.04 |
| Apr 24, 2026 | Alloush Ramsey · officer: Chief Operating Officer | A-Award | 46,863 | $0.00 |
| Apr 24, 2026 | Benesch Joseph · officer: CFO | A-Award | 28,907 | $0.00 |
| Apr 24, 2026 | Alloush Ramsey · officer: Chief Operating Officer | A-Award | 62,795 | $5.04 |
| Apr 24, 2026 | Maraoui Claude · director, officer: President & CEO | A-Award | 49,277 | $0.00 |
| Apr 24, 2026 | Benesch Joseph · officer: CFO | A-Award | 41,860 | $5.04 |
| Aug 26, 2025 | Maraoui Claude · director, officer: President & CEO | F-InKind | 10,877 | $7.47 |
| Aug 26, 2025 | Maraoui Claude · director, officer: President & CEO | M-Exempt | 1,250,000 | $0.07 |
| Aug 7, 2025 | ROSENWALD LINDSAY A MD · director | A-Award | 50,000 | $0.00 |
| Aug 7, 2025 | Smith Justin Adam · director | A-Award | 20,000 | $0.00 |
| Aug 7, 2025 | Toledano Miranda Jayne · director | A-Award | 20,000 | $0.00 |
| Aug 7, 2025 | Pearce Michael Cooper · director | A-Award | 20,000 | $0.00 |
| Aug 7, 2025 | Herskowitz Neil · director | A-Award | 20,000 | $0.00 |
| Jul 7, 2025 | Smith Justin Adam · director | A-Award | 7,173 | $0.00 |
| Jul 7, 2025 | Pearce Michael Cooper · director | A-Award | 7,173 | $0.00 |
| Jul 7, 2025 | ROSENWALD LINDSAY A MD · director | A-Award | 7,173 | $0.00 |
| Jul 7, 2025 | Herskowitz Neil · director | A-Award | 7,173 | $0.00 |
| Jul 7, 2025 | Toledano Miranda Jayne · director | A-Award | 7,173 | $0.00 |
| Jun 20, 2025 | Alloush Ramsey · officer: Chief Operating Officer | A-Award | 62,795 | $6.31 |
| Jun 20, 2025 | Benesch Joseph · officer: CFO | A-Award | 28,907 | $0.00 |
| Jun 20, 2025 | Benesch Joseph · officer: CFO | A-Award | 41,860 | $6.31 |
| Jun 20, 2025 | Maraoui Claude · director, officer: President & CEO | A-Award | 49,277 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 36Increased 53Reduced 42Sold out 23
| Filer | Action | Shares | Filed |
|---|---|---|---|
| WASATCH ADVISORS LP | Increased | 2,858,930 | Jul 10, 2026 |
| WASATCH ADVISORS LP | Increased | 2,133,370 | Apr 21, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Reduced | 1,610,000 | May 15, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Unchanged | 1,610,000 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1,082,080 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 972,862 | May 13, 2026 |
| OPALEYE MANAGEMENT INC. | Reduced | 960,000 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 675,185 | Aug 13, 2026 |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | New Position | 536,000 | Aug 14, 2026 |
| Pale Fire Capital SE | Increased | 528,584 | Aug 13, 2026 |
| J. GOLDMAN & CO LP | Reduced | 500,188 | May 15, 2026 |
| PALE FIRE CAPITAL SE | Increased | 481,987 | May 14, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 463,202 | May 15, 2026 |
| UBS GROUP AG | Increased | 390,138 | May 5, 2026 |
| MILLENNIUM MANAGEMENT LLC | Reduced | 383,067 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 2, 2026